X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14) 14
humans (13) 13
oncology (10) 10
male (8) 8
cancer (7) 7
female (7) 7
article (6) 6
immunotherapy (6) 6
bladder cancer (5) 5
care and treatment (5) 5
middle aged (5) 5
adult (4) 4
aged (4) 4
carcinoma (4) 4
chemotherapy (4) 4
melanoma (4) 4
therapy (4) 4
tumors (4) 4
animals (3) 3
atherosclerosis (3) 3
biomarkers (3) 3
cardiac & cardiovascular systems (3) 3
ctla-4 blockade (3) 3
hematology (3) 3
immune response (3) 3
lymphocytes (3) 3
mice, inbred c57bl (3) 3
mice, knockout (3) 3
nivolumab (3) 3
sensitivity (3) 3
single-arm (3) 3
t cells (3) 3
treatment outcome (3) 3
abridged index medicus (2) 2
aged, 80 and over (2) 2
antibodies (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
apoa-i (2) 2
apolipoproteins e - deficiency (2) 2
athletes (2) 2
b7-h1 antigen - antagonists & inhibitors (2) 2
b7-h1 antigen - immunology (2) 2
biology and life sciences (2) 2
camps (2) 2
cancer therapies (2) 2
cardiovascular (2) 2
cell biology (2) 2
cells (2) 2
cells, cultured (2) 2
chemotherapy, adjuvant (2) 2
cholesterol (2) 2
cisplatin - administration & dosage (2) 2
cisplatin-based chemotherapy (2) 2
drug therapy (2) 2
epidemiology (2) 2
ercc2 (2) 2
evidence-based medicine (2) 2
football (2) 2
gene expression (2) 2
hdl (2) 2
health aspects (2) 2
hematopoiesis (2) 2
hypertension (2) 2
immune checkpoint (2) 2
immune system (2) 2
immune therapy (2) 2
immunology (2) 2
immunotherapy - methods (2) 2
interferon-gamma - metabolism (2) 2
ipilimumab (2) 2
lymph-node dissection (2) 2
lymphocytes t (2) 2
medical prognosis (2) 2
medical research (2) 2
medicine (2) 2
medicine and health sciences (2) 2
metastasis (2) 2
metastatic melanoma (2) 2
mice (2) 2
multicenter (2) 2
muscle-invasive bladder cancer (2) 2
mutation (2) 2
neoadjuvant chemotherapy (2) 2
neoplasm staging (2) 2
package (2) 2
pathological complete response (2) 2
patients (2) 2
pd-l1 (2) 2
pd-l1 protein (2) 2
pembrolizumab (2) 2
peripheral vascular disease (2) 2
pharmacology & pharmacy (2) 2
radical cystectomy (2) 2
regulatory t-cells (2) 2
research (2) 2
research article (2) 2
risk factors (2) 2
rna-seq (2) 2
science (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
PLoS Medicine, ISSN 1549-1277, 05/2017, Volume 14, Issue 5, p. e1002309
Background Inhibition of programmed death-ligand 1 (PD-L1) with atezolizumab can induce durable clinical benefit (DCB) in patients with metastatic urothelial... 
METASTATIC MELANOMA | CTLA-4 BLOCKADE | CELLS | MEDICINE, GENERAL & INTERNAL | REPAIR | THERAPY | DYNAMICS | CARCINOMA | Carcinoma - immunology | Antibodies, Monoclonal - pharmacology | Humans | Middle Aged | Urologic Neoplasms - etiology | Carcinoma - prevention & control | Male | B7-H1 Antigen - immunology | Carcinoma - etiology | Urothelium - pathology | Urologic Neoplasms - immunology | Exome - genetics | B7-H1 Antigen - antagonists & inhibitors | Sequence Analysis, RNA | Aged, 80 and over | Female | Urologic Neoplasms - prevention & control | Aged | Antineoplastic Agents - pharmacology | Receptors, Antigen, T-Cell - genetics | Care and treatment | Research | Cancer | Membrane proteins | Urothelium | Therapy | Correlation | Science | Staining | Lymphocytes T | Metastasis | Cancer therapies | Blood | Clinical outcomes | Loads (forces) | Gene sequencing | Metastases | T-cell receptor | Missense mutation | Lymphocytes | Data integration | Peripheral blood | Interrogation | Genetics | Inhibition | Pretreatment | Urothelial carcinoma | Immune system | Medical research | Urothelial cancer | Load | Integration | Immune response | Cell survival | Mortality | Melanoma | Durability | T cell receptors | Ribonucleic acid--RNA | Patients | Survival | Medicine | Chemotherapy | Sensitivity | Immune checkpoint | Medical prognosis | PD-L1 protein | Death | Infiltration | Mutation | Tumors | Apoptosis | RNA | Ribonucleic acid
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 1714 - 1714
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e16035 - e16035
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2016, Volume 22, Issue 10, pp. 2323 - 2328
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 07/2011, Volume 31, Issue 7, pp. 1565 - 1572
OBJECTIVE—Interleukin 17A (IL17A) is involved in many inflammatory processes, but its role in atherosclerosis remains controversial. We examined the role of... 
atherosclerosis | nitric oxide | cytokines | vascular biology | superoxide | IL-17A | INTACT | FOAM CELLS | PLAQUE | MONOCYTE MIGRATION | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | T-CELLS | Antibodies, Neutralizing - administration & dosage | Inflammation - pathology | Spleen - immunology | Apolipoproteins E - deficiency | Atherosclerosis - genetics | Dendritic Cells - immunology | Humans | Middle Aged | Interleukin-17 - immunology | Male | Aorta - metabolism | Interferon-gamma - metabolism | Aortic Diseases - metabolism | Inflammation - metabolism | Ligation | Lymphocytes - immunology | Time Factors | Carotid Artery Diseases - pathology | Dietary Fats | Superoxides - metabolism | Female | Angiotensin II | Carotid Artery Diseases - metabolism | Aortic Diseases - pathology | Disease Models, Animal | Carotid Artery Diseases - immunology | Interleukin-17 - blood | Atherosclerosis - pathology | Atherosclerosis - immunology | Aortic Diseases - immunology | Mice, Inbred C57BL | Cells, Cultured | Interleukin-17 - genetics | Aorta - immunology | Inflammation - immunology | Interleukin-17 - deficiency | Atherosclerosis - metabolism | Mice, Knockout | Interleukin-17 - metabolism | Aortic Diseases - genetics | Animals | Apolipoproteins E - genetics | Carotid Artery Diseases - genetics | Inflammation - genetics | Carotid Arteries - surgery | Aged | Mice | Nitric Oxide - metabolism | Interferon-gamma | Reactive oxygen species | Apolipoprotein E | Interleukin 17 | Atherosclerosis
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 4533 - 4533
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 09/2019, Volume 37, Issue 26, pp. 2329 - 2329
PURPOSE In men with metastatic germ cell tumors (GCTs), risk-directed treatment is determined, in part, by a distinction between seminoma and nonseminomatous... 
LYMPH-NODE DISSECTION | LONG-TERM | HIGH-DOSE CARBOPLATIN | CISPLATIN | ONCOLOGY | POOR-RISK PATIENTS | BONE-MARROW-TRANSPLANTATION | TESTICULAR CANCER | COMBINATION CHEMOTHERAPY | 1ST-LINE THERAPY | CARCINOMA | Index Medicus
Journal Article
Cell Reports, ISSN 2211-1247, 04/2018, Volume 23, Issue 2, pp. 512 - 521
It has been posited that anti-tumoral innate activation is driven by derepression of endogenous repeats. We compared RNA sequencing protocols to assess repeat... 
microenvironment | HSATII | RNA-seq | innate immunity | immunotherapy | ERV | repetitive elements | cancer immunity | IMMUNITY | INTERFERON RESPONSE | INSTABILITY | MELANOMA | DNA METHYLATION | REPETITIVE ELEMENTS | NONCODING RNAS | PACKAGE | P53 | CELL BIOLOGY
Journal Article
Oncology (Williston Park, N.Y.), ISSN 0890-9091, 11/2014, Volume 28, pp. 6 - 14
Journal Article
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 06/2019, p. JCO1801608
In men with metastatic germ cell tumors (GCTs), risk-directed treatment is determined, in part, by a distinction between seminoma and nonseminomatous GCT... 
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 03/2015, Volume 125, Issue 3, pp. 1189 - 1189
In this paper, the authors determined that loss of LNK exacerbates angiotensin II-induced (Ang II-induced) hypertension and the associated renal and vascular... 
Journal Article
The American Journal of Cardiology, ISSN 0002-9149, 03/2011, Volume 107, Issue 5, p. 755
  Pulmonary hypertension (PH) is a common sequela of degenerative mitral valve disease, but the regression of PH after mitral surgery is often incomplete. We... 
Hypertension | Heart surgery | Medical prognosis | Cardiovascular disease | Cardiology | Epidemiology | Risk factors
Journal Article